Correlation Between GlaxoSmithKline PLC and Ensurge

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Ensurge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Ensurge into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Ensurge, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Ensurge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Ensurge. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Ensurge.

Diversification Opportunities for GlaxoSmithKline PLC and Ensurge

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Ensurge is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Ensurge in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensurge and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Ensurge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensurge has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Ensurge go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Ensurge

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 8.45 times less return on investment than Ensurge. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 4.34 times less risky than Ensurge. It trades about 0.01 of its potential returns per unit of risk. Ensurge is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  0.02  in Ensurge on August 25, 2024 and sell it today you would earn a total of  0.00  from holding Ensurge or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Ensurge

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Ensurge 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ensurge has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical and fundamental indicators, Ensurge is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

GlaxoSmithKline PLC and Ensurge Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Ensurge

The main advantage of trading using opposite GlaxoSmithKline PLC and Ensurge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Ensurge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensurge will offset losses from the drop in Ensurge's long position.
The idea behind GlaxoSmithKline PLC ADR and Ensurge pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.